Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: 4DMedical, Abbisko, Eisai, GSK, Merck, SS Innovations.

Biopharma and med-tech happenings in Asia-Pacific, including deals and partnerships, and other news in brief: Adagene, Amgen, AP Biosciences, Aurinia, Axsome, Biocytogen, Daiichi Sankyo, Enodia, Everest Medicines, Frontier Medicines, Incyte, Kezar, LG Chem, Lupin, Nuvation, Shionogi, Taisho, Takeda, Tanabe, Tasly, Visufarma, Zai Lab.

Clinical updates for biopharma and med tech in Asia-Pacific, including data readouts and publications: Adagene, Braveheart, Connect, Gan & Lee, Hengrui, Simcere, Takeda.

Biopharma and med-tech companies in Asia-Pacific raising money in public or private financings: 4DMedical, Adagene, Hangzhou Diagens, Stairmed.

New hires and promotions in the biopharma and med-tech industries in Asia-Pacific, including: Telix, Transcenta.

BioWorld Asia briefs for April 7, 2026

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Cocrystal, Context, Fore, Eli Lilly, Merck, Ultragenyx, Zeto.

Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Adagene, Axsome, Boston Scientific, BSM, Ellipsys, Gilead, Incyte, Lupin, Oncotelics, Phil, Shionogi, Takeda, Tanabe, Techforce, Tenpoint, Valencia, Visufarma.

Clinical updates for biopharma and med tech, including data readouts and publications: Adagene, Alto Neuroscience, Astrazeneca, Beam, Immunovant, Lipocine, Neutrolis, Novo Nordisk, Pangia, Puretech, Seaport, Soligenix, Vascarta.

Biopharma and med-tech companies raising money in public or private financings, including: Adagene, Arch Biopartners, Celldex, Entera, Hoth, Inovio, Stairmed.